Blood cancers, Myelofibrosis, Polycythaemia, Thrombocythaemia
Results
Phase 2
This study was for people with a type of blood cancer that causes the bone marrow to produce too many blood cells. This includes:
These conditions are also called myeloproliferative neoplasms or myeloproliferative disorders.
The study was open for people to join between 2016 and 2019. The team published the results in 2023.
Recruitment start: 26 August 2016
Recruitment end: 20 June 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Claire Harrison
Bloodwise TAP
University of Birmingham
Last reviewed: 22 October 2024
CRUK internal database number: 14193
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
